Concepedia

Publication | Open Access

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

DOIFull Paper Access

401

Citations

32

References

2019

Year

John P. Leonard, Marek Trněný, Koji Izutsu, Nathan Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner, Adriana Scheliga, Grzegorz S. Nowakowski,
Journal of Clinical Oncology

Abstract

Lenalidomide improved efficacy of rituximab in patients with recurrent indolent lymphoma, with an acceptable safety profile.

References

YearCitations

Page 1